Early research (Phase 1)Study completedNCT01968486
What this trial is testing
Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia
Who this might be right for
Myopia, Degenerative
University of Campania Luigi Vanvitelli 60